Gilead Sciences Inc. / Triangle Pharmaceuticals Inc.
2003 · Acquisition/Merger · $464M · Complete
Announcement Sentiment
100
Strongly positive
Announced Dec 2002, closed January 23, 2003. $6/share = $464M cash. Acquired emtricitabine (Coviracil/FTC) — became core to Truvada/Atripla franchises. Sources: Gilead 1/23/2003 press release, SEC.